File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/00005344-199106000-00016
- Scopus: eid_2-s2.0-0025948189
- PMID: 1714022
- WOS: WOS:A1991FQ07100016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Nebivolol induces endothelium-dependent relaxations of canine coronary arteries
Title | Nebivolol induces endothelium-dependent relaxations of canine coronary arteries |
---|---|
Authors | |
Keywords | Endothelium-derived relaxing factor Membrane potential Methylene blue Methysergide Nitro-L-arginine Phentolamine Propranolol |
Issue Date | 1991 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ |
Citation | Journal Of Cardiovascular Pharmacology, 1991, v. 17 n. 6, p. 964-969 How to Cite? |
Abstract | Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing cardiac function. The present study was designed to determine the effect of nebivolol on coronary arteries. Rings of canine left anterior descending coronary (LAD) artery with or without endothelium were suspended in organ chambers and the isometric tension was recorded. In some experiments, the transmembrane potential of the smooth muscle cells was recorded by electrophysiological methods. During contractions to prostaglandin F(2α), nebivolol induced concentration-dependent relaxations of the coronary arteries. The enantiomer, l-nebivolol, also induced comparable relaxations; however, d-nebivolol induced smaller relaxations. The relaxations induced by nebivolol and its enantiomer were significantly larger in tissues with than in those without endothelium. The differences between tissues with and without endothelium were abolished by nitro-L-arginine (3 x 10-5 M) or methylene blue (10-5 M). The nebivolol-induced relaxations were not affected by indomethacin (10-5 M), phentolamine (5 x 10-6 M), propranolol (5 x 10-6 M), or methysergide (3 x 10-6 M). Nebivolol at a subthreshold concentration for inducing relaxation (3 x 10-7 M) did not significantly affect endothelium-dependent relaxations to acetylcholine but potentiated ADP-induced endothelium-dependent relaxations. The potentiation is stereoselective for l-nebivolol. Nebivolol induced a small hyperpolarization of the coronary smooth muscle with endothelium (1 mV). These observations demonstrate that (a) nebivolol induces relaxations of canine coronary arteries that are mainly mediated by endothelium-derived relaxing factor(s); these effects are not related to the α- and β-adrenergic- or serotonergic 5-HT1- and 5-HT2-blocking properties of the compound; (b) nebivolol potentiates ADP-induced endothelium-dependent relaxations; and (c) l-nebivolol is more potent than d-nebivolol in inducing and potentiating endothelium-dependent relaxations. |
Persistent Identifier | http://hdl.handle.net/10722/171018 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.610 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gao, Y | en_US |
dc.contributor.author | Nagao, T | en_US |
dc.contributor.author | Bond, RA | en_US |
dc.contributor.author | Janssens, WJ | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:51Z | - |
dc.date.available | 2012-10-30T06:11:51Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Journal Of Cardiovascular Pharmacology, 1991, v. 17 n. 6, p. 964-969 | en_US |
dc.identifier.issn | 0160-2446 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171018 | - |
dc.description.abstract | Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing cardiac function. The present study was designed to determine the effect of nebivolol on coronary arteries. Rings of canine left anterior descending coronary (LAD) artery with or without endothelium were suspended in organ chambers and the isometric tension was recorded. In some experiments, the transmembrane potential of the smooth muscle cells was recorded by electrophysiological methods. During contractions to prostaglandin F(2α), nebivolol induced concentration-dependent relaxations of the coronary arteries. The enantiomer, l-nebivolol, also induced comparable relaxations; however, d-nebivolol induced smaller relaxations. The relaxations induced by nebivolol and its enantiomer were significantly larger in tissues with than in those without endothelium. The differences between tissues with and without endothelium were abolished by nitro-L-arginine (3 x 10-5 M) or methylene blue (10-5 M). The nebivolol-induced relaxations were not affected by indomethacin (10-5 M), phentolamine (5 x 10-6 M), propranolol (5 x 10-6 M), or methysergide (3 x 10-6 M). Nebivolol at a subthreshold concentration for inducing relaxation (3 x 10-7 M) did not significantly affect endothelium-dependent relaxations to acetylcholine but potentiated ADP-induced endothelium-dependent relaxations. The potentiation is stereoselective for l-nebivolol. Nebivolol induced a small hyperpolarization of the coronary smooth muscle with endothelium (1 mV). These observations demonstrate that (a) nebivolol induces relaxations of canine coronary arteries that are mainly mediated by endothelium-derived relaxing factor(s); these effects are not related to the α- and β-adrenergic- or serotonergic 5-HT1- and 5-HT2-blocking properties of the compound; (b) nebivolol potentiates ADP-induced endothelium-dependent relaxations; and (c) l-nebivolol is more potent than d-nebivolol in inducing and potentiating endothelium-dependent relaxations. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.cardiovascularpharm.com/ | en_US |
dc.relation.ispartof | Journal of Cardiovascular Pharmacology | en_US |
dc.subject | Endothelium-derived relaxing factor | - |
dc.subject | Membrane potential | - |
dc.subject | Methylene blue | - |
dc.subject | Methysergide | - |
dc.subject | Nitro-L-arginine | - |
dc.subject | Phentolamine | - |
dc.subject | Propranolol | - |
dc.subject.mesh | Adrenergic Beta-Antagonists - Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Benzopyrans - Pharmacology | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Physiology | en_US |
dc.subject.mesh | Dinoprost - Pharmacology | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Electrophysiology | en_US |
dc.subject.mesh | Endothelium, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Ethanolamines - Pharmacology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Membrane Potentials - Drug Effects | en_US |
dc.subject.mesh | Muscle Contraction - Drug Effects | en_US |
dc.subject.mesh | Muscle Relaxation - Drug Effects - Physiology | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Cytology - Drug Effects - Physiology | en_US |
dc.title | Nebivolol induces endothelium-dependent relaxations of canine coronary arteries | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1097/00005344-199106000-00016 | - |
dc.identifier.pmid | 1714022 | - |
dc.identifier.scopus | eid_2-s2.0-0025948189 | en_US |
dc.identifier.volume | 17 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.spage | 964 | en_US |
dc.identifier.epage | 969 | en_US |
dc.identifier.isi | WOS:A1991FQ07100016 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Gao, Y=7404706442 | en_US |
dc.identifier.scopusauthorid | Nagao, T=7401489430 | en_US |
dc.identifier.scopusauthorid | Bond, RA=7102696356 | en_US |
dc.identifier.scopusauthorid | Janssens, WJ=7006876881 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0160-2446 | - |